DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,504 filers reported holding DANAHER CORPORATION in Q4 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,998,719 | +3.6% | 20,148 | +0.2% | 3.35% | +15.9% |
Q2 2023 | $4,824,000 | -0.9% | 20,100 | +4.1% | 2.90% | -6.4% |
Q1 2023 | $4,867,901 | +8.3% | 19,314 | +14.1% | 3.09% | -22.9% |
Q4 2022 | $4,493,030 | +2.8% | 16,928 | 0.0% | 4.01% | -2.5% |
Q3 2022 | $4,372,000 | +1.8% | 16,928 | -0.0% | 4.11% | +1.1% |
Q2 2022 | $4,293,000 | -14.2% | 16,932 | -0.8% | 4.07% | +2.9% |
Q1 2022 | $5,006,000 | -44.2% | 17,065 | -37.4% | 3.95% | -5.8% |
Q4 2021 | $8,976,000 | +6.1% | 27,281 | -1.8% | 4.20% | -4.8% |
Q3 2021 | $8,459,000 | +13.9% | 27,786 | +0.4% | 4.41% | +8.1% |
Q2 2021 | $7,429,000 | +18.0% | 27,684 | -1.0% | 4.08% | +12.7% |
Q1 2021 | $6,295,000 | +27.1% | 27,969 | +25.5% | 3.62% | -3.9% |
Q4 2020 | $4,951,000 | +8.1% | 22,286 | +4.8% | 3.77% | -19.5% |
Q3 2020 | $4,581,000 | -15.7% | 21,273 | -30.8% | 4.68% | +10.7% |
Q2 2020 | $5,433,000 | +29.2% | 30,726 | +1.2% | 4.22% | +4.5% |
Q1 2020 | $4,204,000 | -27.0% | 30,371 | -19.0% | 4.04% | -16.0% |
Q4 2019 | $5,755,000 | +6.1% | 37,497 | -0.2% | 4.81% | +4.4% |
Q3 2019 | $5,425,000 | -19.0% | 37,560 | -19.8% | 4.61% | -20.3% |
Q2 2019 | $6,695,000 | +8.9% | 46,846 | +0.6% | 5.78% | +1.6% |
Q1 2019 | $6,150,000 | +31.8% | 46,586 | +2.9% | 5.68% | +3.9% |
Q4 2018 | $4,666,000 | – | 45,252 | – | 5.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |